241
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Early Detection of Renal Impairment Among Patients with Type 2 Diabetes Mellitus Through Evaluation of Serum Cystatin C in Comparison with Serum Creatinine Levels: A Cross-Sectional Study

, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 4727-4735 | Published online: 03 Dec 2020

References

  • Ashwin K, Kumar A. Serum cystatin C and serum creatinine levels in type 2 diabetes mellitus. Int J Res Med Sci. 2015;3(1):174–177.
  • Aksun S, Öncel T, Avşar C, Demir L, Tengiz F, Narin F. Condition Assessment Study For More Effective Medical Biochemistry Education. Clin Chem Lab Med. 2018;56:11.
  • Aksun S, Öncel T. Condition Assessment Study for More Effective Medical Biochemistry Education. Clin Chem Lab Med;56; 2018.
  • Shima T, Khatun A, Yeasmin F, Ferdousi S, Kirtania K, Sultana N. Cystatin C: a better predictor of kidney function in diabetic patients. Bangladesh J Med Biochem. 2011;4(1):16–20. doi:10.3329/bjmb.v4i1.13777
  • Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006;145(4):237–246. doi:10.7326/0003-4819-145-4-200608150-00003
  • Richard M, Erosha Premaratne JG. Estimating glomerular filtration rate in diabetes using serum cystatin C. Clin Biochem Rev. 2011;32:61–67.
  • Andreoli ET, Fitz JG, Benjamin I. Andreoli and Carpenter’s Cecil Essentials of Medicine E-Book. Elsevier Health Sciences; 2010.
  • Borges RL, Hirota AH, Quinto BM, Ribeiro AB, Zanella MT, Batista MC. Is cystatin C a useful marker in the detection of diabetic kidney disease? Nephron Clin Pract. 2010;114(2):c127–c34. doi:10.1159/000254385
  • Singh R, Bhattacharya AB, Saxena S. A comparison of diagnostic accuracy of cystatin C with creatinine in the sample of patient of t2 dm with diabetic nephropathy. 2020.
  • Ahamed SM, Zeratsion R, Elfaki I, Modawe G. Assessment of renal function of eritrean diabetic patients using the GFR derived from the serum levels creatinine, cystatin C or creatinine-Cystatin C. 2020
  • Elbarbary HS, Nabil A, Shoaib AA, El-deen SMK. Serum cystatin C an early indicator of renal function decline in type 2 diabetes. Am J BioSci. 2014;2(3):89–94. doi:10.11648/j.ajbio.20140203.12
  • Alehagen U, Dahlström U, Lindahl TL. Cystatin C and NT proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10‐year study in primary care. Eur J Heart Fail. 2009;11(4):354–360. doi:10.1093/eurjhf/hfp024
  • Pandey KK, Singh N, Raizada A. Evaluation of Serum Cystatin-C and Serum Creatinine Levels in Type-2 DM. 2020.
  • TaghizadehAfshari A, Alizadeh M, MohammadiFallah M, et al. Serum cystatin C versus creatinine in the assessment of allograft function in early periods of kidney transplantation. J Renal Injury Prevent. 2018;7(1):11–15. doi:10.15171/jrip.2018.03
  • Ix JH, Shlipak MG, Chertow GM. Clinical Perspective. Circulation. 2007;115(2):173–179. doi:10.1161/CIRCULATIONAHA.106.644286
  • Finney H, Newman DJ, Gruber W, Merle P, Price CP. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem. 1997;43(6):1016–1022. doi:10.1093/clinchem/43.6.1016
  • Miao Y, Zhong Y, Yan H, Li W, Wang B-Y JJ. Alprostadil plays a protective role in contrast-induced nephropathy in the elderly. Int Urol Nephrol. 2013;45(4):1179–1185. doi:10.1007/s11255-013-0484-1
  • Lujambio I, Sottolano M, Luzardo L, et al. Estimation of glomerular filtration rate based on serum cystatin C versus creatinine in a Uruguayan population. Int J Nephrol. 2014;2014.
  • Tsai C-W, Grams ME, Inker LA, Coresh J, Selvin E. Cystatin C–and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the US. Diabetes Care. 2014;37(4):1002–1008. doi:10.2337/dc13-1910
  • Grubb A. Shrunken pore syndrome – a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options. Clin Biochem. 2020;83:12–20.
  • Åkesson A, Lindström V, Nyman U, et al. Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities. Scand J Clin Lab Invest. 2020;80:412–422. doi:10.1080/00365513.2020.1759139
  • Grubb A. Cystatin C is indispensable for evaluation of kidney disease. (2017): 276.http://www.ifcc.org/media/476805/ejifcc2017vol28no4pp268-276.pdf.
  • McLeod S. What a p-value tells you about statistical significance. Luettavissa. 2019;2020.